SCHEMBL6175174

SCHEMBL6175174

CC1(Cc2ccnc(C(=O)Nc3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.47
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EPHX2 P34913 2/20 0.41
RAF1 P04049 1/20 0.41
KDR P35968 4/20 0.41
FLT1 P17948 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 2/20 0.41
NAMPT P43490 2/20 0.40
NR3C1 P04150 1/20 0.40
GRM1 Q13255 1/20 0.40
IGF1R P08069 1/20 0.39
PTGS2 P35354 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172261 0.89 IGF1R (0.49) ABL1EPHX2RAF1KDRFLT1
SCHEMBL6177034 0.88 IGF1R (0.40) L3MBTL1IGF1RPTGS2
SCHEMBL6173728 0.88 MEN1 (0.47) NPC1RAB9AMEN1KMT2AEPHX2
SCHEMBL6173853 0.87 IGF1R (0.37) L3MBTL1KMT2AEPHX2IGF1RPTGS2
SCHEMBL6174831 0.86 IGF1R (0.41) KMT2ANAMPTGRM1IGF1R
SCHEMBL6172594 0.84 AR (0.40) ABL1L3MBTL1MEN1KMT2AEPHX2
SCHEMBL6175032 0.83 MAPK1 (0.43) MEN1KMT2AEPHX2NAMPTIGF1R
SCHEMBL6171765 0.83 IGF1R (0.41) MEN1KMT2AEPHX2KDRFLT1
SCHEMBL6171575 0.83 IGF1R (0.40) L3MBTL1IGF1RPTGS2
SCHEMBL6173499 0.83 IGF1R (0.38) ABL1EPHX2RAF1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed